Dendritic cells: Cellular mediators for immunological tolerance

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Chung, Chun Yuen J ^a   Ysebaert, Dirk ^a   Berneman, Zwi N ^a,b   Cools, Nathalie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD103 ANTIGEN; CD123 ANTIGEN; CD40 ANTIGEN; DEXAMETHASONE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T6 ANTIGEN; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR ALPHA; AUTOANTIGEN; MONOCLONAL ANTIBODY;

AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SUBPOPULATION; CLONAL ANERGY; CYTOKINE RELEASE; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; ANIMAL; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; CELL COMMUNICATION; CLINICAL TRIAL (TOPIC); IMMUNOLOGY; IMMUNOTHERAPY; PATHOLOGY; AUTOIMMUNE DISEASES; GRAFT VS HOST DISEASE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL COMMUNICATION; CLINICAL TRIALS AS TOPIC; DENDRITIC CELLS; GRAFT VS HOST DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; T-LYMPHOCYTES, REGULATORY;

EID: 84878642259     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/972865     Document Type: Review

References (76)

1. Cools N., Ponsaerts P., Van Tendeloo V. F. I., Berneman Z. N., Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. Journal of Leukocyte Biology 2007 82 6 1365 1374 2-s2.0-35549004528 10.1189/jlb.0307166 (Pubitemid 350276946)
2. Cools N., Petrizzo A., Smits E. L., Buonaguro F. M., Tornesello M. L., Berneman Z. N., Buonaguro L., Dendritic cells in the pathogenesis & treatment of human diseases: a Janus bifrons? Immunotherapy 2011 3 10 1203 1222
3. Steinman R. M., Banchereau J., Taking dendritic cells into medicine. Nature 2007 449 7161 419 426 2-s2.0-34848837386 10.1038/nature06175 (Pubitemid 47509552)
4. Merad M., Sathe P., Helft J., Miller J., Mortha A., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. The Annual Review of Immunology 2013 31 563 604
5. Mahnke K., Schmitt E., Bonifaz L., Enk A. H., Jonuleit H., Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunology and Cell Biology 2002 80 5 477 483 2-s2.0-0036378101 10.1046/j.1440-1711.2002. 01115.x
6. Kalinski P., Urban J., Narang R., Berk E., Wieckowski E., Muthuswamy R., Dendritic cell-based therapeutic cancer vaccines: what we have and what we need. Future Oncology 2009 5 3 379 390
7. Kalinski P., Dendritic cells in immunotherapy of established cancer: roles of signals 1, 2, 3 and 4. Current Opinion in Investigational Drugs 2009 10 6 526 535 2-s2.0-67650650986
8. Bakdash G., Sittig S. P., van Dijk T., Figdor C. G., de Vries I. J., The nature of activatory and tolerogenic dendritic cell-derived signal II. Frontiers in Immunology 2013 4, article 53
9. Van Brussel I., Bernemand Z. N., Cools N., Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system. Mediators of Inflammation 2012 2012 14 690643
10. Curtsinger J. M., Gerner M. Y., Lins D. C., Mescher M. F., Signal 3 availability limits the CD8 T cell response to a solid tumor. Journal of Immunology 2007 178 11 6752 6760 2-s2.0-34249780834 (Pubitemid 46847399)
11. Curtsinger J. M., Valenzuela J. O., Agarwal P., Lins D., Mescher M. F., Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. Journal of Immunology 2005 174 8 4465 4469 2-s2.0-18344362061
12. + T cells. Journal of Immunology 1999 162 6 3256 3262 2-s2.0-0033559126 (Pubitemid 29313572)
13. + T cell responses via a combination of signals mediated by dendritic cells. Journal of Immunology 2007 179 5 2870 2879 2-s2.0-38449112037
14. Hivroz C., Chemin K., Tourret M., Bohineust A., Crosstalk between T lymphocytes and dendritic cells. Critical Reviews in Immunology 2012 32 2 139 155
15. Dörner T., Jacobi A. M., Lipsky P. E., B cells in autoimmunity. Arthritis Research & Therapy 2009 11 5, article 247
16. Kasper L. H., Shoemaker J., Multiple sclerosis immunology: the healthy immune system vs the MS immune system. Neurology 2010 74 supplement 1 S2 S8 2-s2.0-74249086662 10.1212/WNL.0b013e3181c97c8f
17. Hilkens C. M. U., Isaacs J. D., Thomson A. W., Development of dendritic cell-based immunotherapy for autoimmunity. International Reviews of Immunology 2010 29 2 156 183 2-s2.0-77952538760 10.3109/08830180903281193
18. Steinman R. M., Nussenzweig M. C., Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 351 358 2-s2.0-0037039379 10.1073/pnas.231606698 (Pubitemid 34060366)
19. Zehn D., Bevan M. J., T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity 2006 25 2 261 270 2-s2.0-33747092627 10.1016/j.immuni.2006.06.009 (Pubitemid 44224142)
20. Westerberg L. S., Klein C., Snapper S. B., Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency-lessons learned from monogenic disorders in mice and men. Current Opinion in Immunology 2008 20 6 646 654 2-s2.0-56349102675 10.1016/j.coi.2008.10.004
21. Cools N., Ponsaerts P., Van Tendeloo V. F. I., Berneman Z. N., Regulatory T cells and human disease. Clinical and Developmental Immunology 2007 2007 2-s2.0-38649113578 10.1155/2007/89195 89195 (Pubitemid 351171869)
22. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 12 4 431 440 2-s2.0-0033682056
23. Zozulya A. L., Wiendl H., The role of regulatory T cells in multiple sclerosis. Nature Clinical Practice Neurology 2008 4 7 384 398 2-s2.0-48949116961 10.1038/ncpneuro0832 (Pubitemid 352003290)
24. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. Journal of Experimental Medicine 2000 192 9 1213 1222 2-s2.0-0034613767 10.1084/jem.192.9.1213
25. Schmidt S. V., Nino-Castro A. C., Schultze J. L., Regulatory dendritic cells: there is more than just immune activation. Frontiers in Immunology 2012 3, article 274
26. Bagavant H., Thompson C., Ohno K., Setiady Y., Tung K. S. K., Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease. International Immunology 2002 14 12 1397 1406 2-s2.0-0036914841 10.1093/intimm/dxf105 (Pubitemid 36024605)
27. + T regulatory cells. Journal of Experimental Medicine 2004 199 3 323 335 2-s2.0-1342342922 10.1084/jem.20031137 (Pubitemid 38252045)
28. Ohnmacht C., Pullner A., King S. B. S., Drexler I., Meier S., Brocker T., Voehringer D., Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. Journal of Experimental Medicine 2009 206 3 549 559 2-s2.0-63449108301 10.1084/jem.20082394
29. Sawatani Y., Miyamoto T., Nagai S., Maruya M., Imai J., Miyamoto K., Fujita N., Ninomiya K., Suzuki T., Iwasaki R., Toyama Y., Shinohara M., Koyasu S., Suda T., The role of DC-STAMP in maintenance of immune tolerance through regulation of dendritic cell function. International Immunology 2008 20 10 1259 1268 2-s2.0-52949098785 10.1093/intimm/dxn082
30. Edelmann S. L., Marconi P., Brocker T., Peripheral T cells re-enter the thymus and interfere with central tolerance induction. Journal of Immunology 2011 186 10 5612 5619 2-s2.0-79956211174 10.4049/jimmunol.1004010
31. Legge K. L., Gregg R. K., Maldonado-Lopez R., Li L., Caprio J. C., Moser M., Zaghouani H., On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. Journal of Experimental Medicine 2002 196 2 217 227 2-s2.0-0037099710 10.1084/jem.20011061 (Pubitemid 34787511)
32. Nuyts A., Lee W., Bashir-Dar R., Berneman Z., Cools N., Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies? Multiple Sclerosis Journal 2013 10.1177/1352458512473189
33. Mohammad M. G., Hassanpour M., Tsai V. W., Li H., Ruitenberg M. J., Booth D. W., Serrats J., Hart P. H., Symonds G. P., Sawchenko P. E., Breit S. N., Brown D. A., Dendritic cells and multiple sclerosis: disease, tolerance and therapy. International Journal of Molecular Sciences 2012 14 1 547 562
34. Carvalheiro T., Rodrigues A., Lopes A., Inês L., Velada I., Ribeiro A., Martinho A., Silva J. A., Pais M. L., Paiva A., Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus. Clinical and Developmental Immunology 2012 2012 14 934161
35. Chan V. S., Nie Y. J., Shen N., Yan S., Mok M. Y., Lau C. S., Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmunity Reviews 2012 11 12 890 897
36. Broder A., Chan J. J., Putterman C., Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases. Clinical Immunology 2013 146 3 197 206
37. Suen J. L., Chuang Y. H., Chiang B. L., In vivo tolerance breakdown with dendritic cells pulsed with U1A protein in non-autoimmune mice: the induction of a high level of autoantibodies but not renal pathological changes. Immunology 2002 106 3 326 335 2-s2.0-0036306501 10.1046/j.1365-2567.2002.01438.x (Pubitemid 34748126)
38. Lebre M. C., Jongbloed S. L., Tas S. W., Smeets T. J. M., McInnes I. B., Tak P. P., Rheumatoid arthritis synovium contains two subsets of CD83 -DC-LAMP- dendritic cells with distinct cytokine profiles. American Journal of Pathology 2008 172 4 940 950 2-s2.0-42049089122 10.2353/ajpath.2008.070703 (Pubitemid 351519991)
39. Bobryshev Y. V., Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. European Heart Journal 2005 26 17 1700 1704 2-s2.0-24044553923 10.1093/eurheartj/ehi282 (Pubitemid 41219842)
40. Lech M., Kulkarni O. P., Pfeiffer S., Savarese E., Krug A., Garlanda C., Mantovani A., Anders H. J., Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. Journal of Experimental Medicine 2008 205 8 1879 1888 2-s2.0-49249109576 10.1084/jem.20072646
41. Hjelmström P., Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. Journal of Leukocyte Biology 2001 69 3 331 339 2-s2.0-0035109174 (Pubitemid 32221435)
42. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R. M., Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. Journal of Experimental Medicine 1998 188 8 1493 1501 2-s2.0-0032547818 10.1084/jem.188.8.1493 (Pubitemid 28489586)
43. Lakey R. L., Morgan T. G., Rowan A. D., Isaacs J. D., Cawston T. E., Hilkens C. M. U., A novel paradigm for dendritic cells as effectors of cartilage destruction. Rheumatology 2009 48 5 502 507 2-s2.0-65249188115 10.1093/rheumatology/kep040
44. Dhodapkar M. V., Steinman R. M., Krasovsky J., Munz C., Bhardwaj N., Antigen-specific inhibition of effector T-cell function in humans after rejection of immature dendritic cells. The Journal of Experimental Medicine 2001 193 2 233 238 (Pubitemid 32524454)
45. Menges M., Rößner S., Voigtländer C., Schindler H., Kukutsch N. A., Bogdan C., Erb K., Schuler G., Lutz M. B., Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. Journal of Experimental Medicine 2002 195 1 15 21 2-s2.0-0037033427 10.1084/jem.20011341 (Pubitemid 34074492)
46. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A. M., Adorini L., Regulatory T cells induced by 1 α25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. Journal of Immunology 2001 167 4 1945 1953 2-s2.0-0035881234 (Pubitemid 32747499)
47. Liu Q., Chen T., Chen G., Shu X., Sun A., Ma P., Lu L., Cao X., Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF- B pathways. Molecular Immunology 2007 44 10 2686 2696 2-s2.0-33846903837 10.1016/j.molimm.2006.12.003 (Pubitemid 46240316)
48. Liu Q., Chen T., Chen G., Li N., Wang J., Ma P., Cao X., Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF- B activation. Biochemical and Biophysical Research Communications 2006 345 3 1122 1130 2-s2.0-33646854369 10.1016/j.bbrc.2006.05.024 (Pubitemid 43776516)
49. Chorny A., Gonzalez-Rey E., Fernandez-Martin A., Pozo D., Ganea D., Delgado M., Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proceedings of the National Academy of Sciences of the United States of America 2005 102 38 13562 13567 2-s2.0-26444591571 10.1073/pnas.0504484102 (Pubitemid 41420888)
50. Gonzalez-Rey E., Chorny A., Fernandez-Martin A., Ganea D., Delgado M., Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Blood 2006 107 9 3632 3638 2-s2.0-33646435802 10.1182/blood-2005-11-4497
51. Hubert P., Jacobs N., Caberg J. H., Boniver J., Delvenne P., The cross-talk between dendritic and regulatory T cells: good or evil? Journal of Leukocyte Biology 2007 82 4 781 794 2-s2.0-34848832026 10.1189/jlb.1106694 (Pubitemid 47511037)
52. Min W. P., Gorczynski R., Huang X. Y., Kushida M., Kim P., Obataki M., Lei L., Suri R. M., Cattral M. S., Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. Journal of Immunology 2000 164 1 161 167 2-s2.0-0033970592 (Pubitemid 30012986)
53. Kaneko K., Wang Z., Kim S. H., Morelli A. E., Robbins P. D., Thomson A. W., Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection. Gene Therapy 2003 10 2 143 152 2-s2.0-0037265249 10.1038/sj.gt. 3301872 (Pubitemid 36582586)
54. Xu H., Chen T., Wang H. Q., Ji M. J., Zhu X., Wu W. X., Prolongation of rat intestinal allograft survival by administration of donor interleukin-12 p35-silenced bone marrow-derived dendritic cells. Transplantation Proceedings 2006 38 5 1561 1563 2-s2.0-33745203675 10.1016/j.transproceed.2006.03.022
55. Giannoukakis N., Bonham C. A., Qian S., Zhou Z., Peng L., Harnaha J., Li W., Thomson A. W., Fung J. J., Robbins P. D., Lu L., Prolongation of cardiac allograft survival using dendritic cells treated with NF- B decoy oligodeoxyribonucleotides. Molecular Therapy 2000 1 5 430 437 2-s2.0-0034184575
56. Zheng X., Vladau C., Zhang X., Suzuki M., Ichim T. E., Zhang Z. X., Li M., Carrier E., Garcia B., Jevnikar A. M., Min W. P., A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood 2009 113 12 2646 2654 2-s2.0-63849265378 10.1182/blood-2008-04-151191
57. Giannoukakis N., Phillips B., Finegold D., Harnaha J., Trucco M., Phase I, (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. Diabetes Care 2011 34 2026 2032
58. Meredith M. M., Liu K., Kamphorst A. O., Idoyaga J., Yamane A., Guermonprez P., Rihn S., Yao K. H., Silva I. T., Oliveira T. Y., Skokos D., Casellas R., Nussenzweig M. C., Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. The Journal of Experimental Medicine 2012 209 9 1583 1593
59. Watkins S. K., Hurwitz A. A., FOXO3: a master switch for regulating tolerance and immunity in dendritic cells. Oncoimmunology 2012 1 2 252 254
60. Boks M. A., Kager-Groenland J. R., Haasjes M. S., Zwaginga J. J., van Ham S. M., ten Brinke A., IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-a comparative study of human clinical -applicable DC. Clinical Immunology 2012 142 3 332 342
61. Volchenkov R., Karlsen M., Jonsson R., Appel S., Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells. Scandinavian Journal of Immunology 2013 77 4 246 254
62. Housley W. J., O'Conor C. A., Nichols F., Puddington L., Lingenheld E. G., Zhu L., Clark R. B., PPAR γ regulates retinoic acid-mediated DC induction of Tregs. Journal of Leukocyte Biology 2009 86 2 293 301 2-s2.0-69449086033 10.1189/jlb.1208733
63. + regulatory T cells via a TGF- β -and retinoic acid-dependent mechanism. Journal of Experimental Medicine 2007 204 8 1757 1764 2-s2.0-34547788180 10.1084/jem.20070590 (Pubitemid 47236314)
64. Sun C. M., Hall J. A., Blank R. B., Bouladoux N., Oukka M., Mora J. R., Belkaid Y., Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. Journal of Experimental Medicine 2007 204 8 1775 1785 2-s2.0-34547757390 10.1084/jem.20070602 (Pubitemid 47236316)
65. + regulatory T cells in the maintenance of immune tolerance. Frontiers in Immunology 2012 3, article 165
66. Gabryšová L., Nicolson K. S., Streeter H. B., Verhagen J., Sabatos-Peyton C. A., Morgan D. J., Wraith D. C., Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. Journal of Experimental Medicine 2009 206 8 1755 1767 2-s2.0-68149100383 10.1084/jem.20082118
67. + T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity. Proceedings of the National Academy of Sciences 2012 109 23 9059 9064
68. Gross C. C., Wiendl H., Dendritic cell vaccination in autoimmune disease. Current Opinion in Rheumatology 2013 25 2 268 274
69. Süss G., Shortman K., A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. Journal of Experimental Medicine 1996 183 4 1789 1796 2-s2.0-0029920922
70. Belz G. T., Behrens G. M. N., Smith C. M., Miller J. F. A. P., Jones C., Lejon K., Garrison Fathman C., Mueller S. N., Shortman K., Carbone F. R., Heath W. R., The CD8 α + dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. Journal of Experimental Medicine 2002 196 8 1099 1104 2-s2.0-0037152141 10.1084/jem.20020861 (Pubitemid 35231768)
71. O'Connell P. J., Son Y. I., Giermasz A., Wang Z., Logar A. J., Thomson A. W., Kalinski P., Type-1 polarized nature of mouse liver CD α-and CD8 α + dendritic cells: Tissue-dependent differences offset CD8 α -related dendritic cell heterogeneity. European Journal of Immunology 2003 33 7 2007 2013 2-s2.0-0041967283 10.1002/eji.200323379 (Pubitemid 37120873)
72. Waithman J., Allan R. S., Kosaka H., Azukizawa H., Shortman K., Lutz M. B., Heath W. R., Carbone F. R., Belz G. T., Skin-derived dendritic cells can mediate deletional tolerance of class i-restricted self-reactive T cells. Journal of Immunology 2007 179 7 4535 4541 2-s2.0-38649138415
73. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J. V., Steinman R. M., Nussenzweig M. C., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. Journal of Experimental Medicine 2001 194 6 769 779 2-s2.0-0035903326 10.1084/jem.194.6.769 (Pubitemid 32983013)
74. + myeloid dendritic cells. Blood 2012 119 10 2284 2292
75. Radford K. J., Caminschi I., New generation of dendritic cell vaccines. Human Vaccines & Immunotherapeutics 2013 9 2
76. Idoyaga J., Fiorese C., Zbytnuik L., Lubkin A., Miller J., Malissen B., Mucida D., Merad M., Steinman R. M., Specialized role of migratory dendritic cells in peripheral tolerance induction. The Journal of Clinical Investigation 2013 123 2 844 854 10. 1172/JCI65260